ESTABLISHMENT OF VISIBLE ANIMAL METASTASIS MODELS FOR HUMAN NASOPHARYNGEAL CARCINOMA BASED ON A FAR-RED FLUORESCENT PROTEIN

YING ZHENG; CHUAN HUANG; ZHIYONG CHENG; MIN CHEN

doi:10.1142/s1793545812500198

[1] A. R. Razak, L. L. Siu, F. F. Liu, E. Ito, B. O'Sullivan, K. Chan, "Nasopharyngeal carcinoma: The next challenges," Eur. J. Cancer 46, 1967 (2010).

[2] A. T. Chan, "Nasopharyngeal carcinoma," Ann. Oncol. 21(7), vii308 (2010).

[3] A. T. Chan, P. M. Teo, P. J. Johnson, "Nasopharyngeal carcinoma," Ann. Oncol. 13, 1007 (2002).

[4] Q. Tao, A. T. Chan, "Nasopharyngeal carcinoma: Molecular pathogenesis and therapeutic developments," Expert Rev. Mol. Med. 9, 1 (2007).

[5] L. B. Song, M. S. Zeng, W. T. Liao, L. Zhang, H. Y. Mo, W. L. Liu, J. Y. Shao, Q. L. Wu, M. Z. Li, Y. F. Xia, L. W. Fu, W. L. Huang, G. P. Dimri, V. Band, Y. X. Zeng, "Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells," Cancer Res. 66, 6225 (2006).

[6] X. Li, X. Liu, C. Y. Li, Y. Ding, D. Chau, G. Li, H. F. Kung, M. C. Lin, Y. Peng, "Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of EpsteinBarr virus encoded LMP-1," Int. J. Oncol. 29, 595 (2006).

[7] F. Su, V. Grijalva, K. Navab, E. Ganapathy, D. Meriwether, S. Imaizumi, M. Navab, A. M. Fogelman, S. T. Reddy, R. Farias-Eisner, "HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer," Mol. Cancer Ther. 11, 1311 (2012).

[8] F. Su, K. R. Kozak, S. Imaizumi, F. Gao, M. W. Amneus, V. Grijalva, C. Ng, A. Wagner, G. Hough, G. Farias-Eisner, G. M. Anantharamaiah, B. J. Van Lenten, M. Navab, A. M. Fogelman, S. T. Reddy, R. Farias-Eisner, "Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer," Proc. Natl. Acad. Sci. USA 107, 19997 (2010).

[9] T. Liu, W. Xie, L. Liu, K. Yao, "Establishment of visualized cell model 5-8F-EGFP of nasopharyngeal carcinoma," J. Cancer Control Treat. 22, 233 (2009).

[10] T. Liu, W. Xie, L. Liu, K. Yao, "Establishment of visualized cell model 6-10B-EGFP of nasopharyngeal carcinoma," J. Univ. S. Chin. (Med. Ed.) 37, 393 (2009).

[11] T. Liu, Y. Ding, W. Xie, Z. Li, X. Bai, X. Li, W. Fang, C. Ren, S. Wang, R. M. Hoffman, K. Yao, "An imageable metastatic treatment model of nasopharyngeal carcinoma," Clin. Cancer Res. 13, 3960 (2007).

[12] A. K. Hadjantonakis, A. Nagy, "The color of mice: In the light of GFP-variant reporters," Histochem. Cell Biol. 115, 49 (2001).

[13] B. P. Cormack, R. H. Valdivia, S. Falkow, "FACSoptimized mutants of the green fluorescent protein (GFP)," GENE 173, 33 (1996).

[14] S. R. McRae, C. L. Brown, G. R. Bushell, "Rapid purification of EGFP, EYFP, and ECFP with high yield and purity," Protein Expr. Purif. 41, 121 (2005).

[15] R. Y. Tsien, "The green fluorescent protein," Ann. Rev. Biochem. 67, 509 (1998).

[16] R. Weissleder, V. Ntziachristos, "Shedding light onto live molecular targets," Nat. Med. 9, 123 (2003).

[17] J. Chu, Z. Zhang, Y. Zheng, J. Yang, L. Qin, J. Lu, Z. L. Huang, S. Zeng, Q. Luo, "A novel far-red bimolecular fluorescence complementation system that allows for efficient visualization of protein interactions under physiological conditions," Biosens. Bioelectron. 25, 234 (2009).

[18] D. Shcherbo, E. M. Merzlyak, T. V. Chepurnykh, A. F. Fradkov, G. V. Ermakova, E. A. Solovieva, K. A. Lukyanov, E. A. Bogdanova, A. G. Zaraisky, S. Lukyanov, D. M. Chudakov, "Bright far-red fluorescent protein for whole-body imaging," Nat. Methods 4, 741 (2007).

[19] H. Luo, J. Yang, H. Jin, C. Huang, J. Fu, F. Yang, H. Gong, S. Zeng, Q. Luo, Z. Zhang, "Tetrameric far-red fluorescent protein as a scaffold to assemble an octavalent peptide nanoprobe for enhanced tumor targeting and intracellular uptake in vivo," FASEB J 25, 1865 (2011).

[20] H. Luo, J. Shi, H. Jin, D. Fan, L. Lu, F. Wang, Z. Zhang, "An (125)I-labeled octavalent peptide fluorescent nanoprobe for tumor-homing imaging in vivo," Biomaterials 33, 4843 (2012).

[21] R. S. Dacosta, Y. Tang, T. Kalliomaki, R. M. Reilly, R. Weersink, A. R. Elford, N. E. Marcon, B. C. Wilson, "In vivo near-infrared fluorescence imaging of human colon adenocarcinoma by specific immunotargeting of a tumor-associated mucin," J. Innov. Opt. Health Sci. 2, 407 (2009).

[22] T. Xiong, Z. Zhang, B. F. Liu, S. Zeng, Y. Chen, J. Chu, Q. Luo, "In vivo optical imaging of human adenoid cystic carcinoma cell metastasis," Oral Oncol. 41, 709 (2005).

[23] J. Fu, X. Yang, G. Quan, H. Gong, "Fluorescence molecular tomography system for in vivo tumor imaging in small animals," Chin. Opt. Lett. 8, 1075 (2010).

[24] X. Yang, H. Gong, J. Fu, G. Quan, C. Huang, Q. Luo, "Molecular imaging of small animals with fluorescent proteins: From projection to multimodality," Comput. Med. Imaging Graph 36, 259 (2012).

[25] J. Wang, L. P. Guo, L. Z. Chen, Y. X. Zeng, S. H. Lu, "Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line," Cancer Res. 67, 3716 (2007).

[26] L. Yin, P. Castagnino, R. K. Assoian, "ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial- mesenchymal transition," Cancer Res. 68, 800 (2008).

[27] R. W. Cho, M. F. Clarke, "Recent advances in cancer stem cells," Curr. Opin. Genet. Dev. 18, 48 (2008).

[28] L. Patrawala, T. Calhoun, R. Schneider-Broussard, J. Zhou, K. Claypool, D. G. Tang, "Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2＋ and ABCG2- cancer cells are similarly tumorigenic," Cancer Res. 65, 6207 (2005).

[29] C. G. Marsden, M. J. Wright, R. Pochampally, B. G. Rowan, "Breast tumor-initiating cells isolated from patient core biopsies for study of hormone action," Meth. Mol. Biol. 590, 363 (2009).

[30] Y. Liang, Z. Zhong, Y. Huang, W. Deng, J. Cao, G. Tsao, Q. Liu, D. Pei, T. Kang, Y. X. Zeng, "Stem-like cancer cells are inducible by increasing genomic instability in cancer cells," J. Biol. Chem. 285, 4931 (2010).

[31] M. A. Goodell, K. Brose, G. Paradis, A. S. Conner, R. C. Mulligan, "Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo," J. Exp. Med. 183, 1797 (1996).

[32] X. W. Ding, J. H. Wu, C. P. Jiang, "ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapy," Life Sci. 86, 631 (2010).

[33] C. Hu, H. Li, J. Li, Z. Zhu, S. Yin, X. Hao, M. Yao, S. Zheng, J. Gu, "Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling," Carcinogenesis 29, 2289 (2008).

[34] H. Zeng, J. W. Park, M. Guo, G. Lin, L. Crandall, T. Compton, X. Wang, X. J. Li, F. P. Chen, R. H. Xu, "Lack of ABCG2 expression and side population properties in human pluripotent stem cells," Stem Cells 27, 2435 (2009).